<DOC>
	<DOCNO>NCT01703585</DOCNO>
	<brief_summary>This feasibility study look genetic alteration tissue blood sample may useful determine treatment may useful patient 's cancer care .</brief_summary>
	<brief_title>Feasibility Study Genomic Profiling Methods Timing Tumor Samples</brief_title>
	<detailed_description>As part study , patient archival tumor tissue collect , tumor biopsy blood sample take . The sample test genetic alteration , result discuss patient include potential treatment . If patient agree , receive treatment cancer disease progress , second biopsy procedure do .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Age â‰¥ 18 year . Histological cytological proof either metastatic breast , colorectal , gynecological melanoma malignancy . At least one biopsiable lesion deem medically accessible safe biopsy . Candidate one phase I II clinical trial time study enrollment later time point . Fulfills local institution 's laboratory parameter tumor biopsy . Willingness ability patient provide sign voluntary informed consent . Any condition could interfere patient 's ability provide inform consent dementia severe cognitive impairment . Any contraindication undergo biopsy procedure .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>genomic analysis</keyword>
	<keyword>genome</keyword>
	<keyword>tumor</keyword>
	<keyword>tissue</keyword>
	<keyword>archival</keyword>
	<keyword>biopsy</keyword>
	<keyword>core needle</keyword>
	<keyword>fine needle</keyword>
	<keyword>DNA</keyword>
	<keyword>gene</keyword>
	<keyword>expression</keyword>
	<keyword>sequence</keyword>
</DOC>